{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:43:41Z","timestamp":1790829821339,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"vor","delay-in-days":75,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro (AIRC)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministero della Salute RF-2013","award":["GR-2013-02356568 (PV)"],"award-info":[{"award-number":["GR-2013-02356568 (PV)"]}]},{"name":"Ministero della Salute RF-2013","award":["RC-2018 OPBG (PV and LM)"],"award-info":[{"award-number":["RC-2018 OPBG (PV and LM)"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.imlet.2018.11.004","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T02:43:08Z","timestamp":1541990588000},"page":"14-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes?"],"prefix":"10.1016","volume":"201","author":[{"given":"Paola","family":"Vacca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Munari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Tumino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Moretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Pietra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5372-7885","authenticated-orcid":false,"given":"Massimo","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7272-7776","authenticated-orcid":false,"given":"Genny","family":"Del Zotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Romana","family":"Mariotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Mingari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Moretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6013","key":"10.1016\/j.imlet.2018.11.004_bib0005","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.imlet.2018.11.004_bib0010","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2018.11.004_bib0015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.imlet.2018.11.004_bib0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000365632","article-title":"Human natural killer cells: origin, receptors, function, and clinical applications","volume":"164","author":"Moretta","year":"2014","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2018.11.004_bib0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/ni0102-6","article-title":"What is a natural killer cell?","volume":"3","author":"Moretta","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2018.11.004_bib0030","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev.immunol.14.1.619","article-title":"Receptors for HLA class-I molecules in human natural killer cells","volume":"14","author":"Moretta","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imlet.2018.11.004_bib0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","article-title":"Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis","volume":"19","author":"Moretta","year":"2001","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2018.11.004_bib0040","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/1521-4141(200205)32:5<1205::AID-IMMU1205>3.0.CO;2-Y","article-title":"Human natural killer cells: their origin, receptors and function","volume":"32","author":"Moretta","year":"2002","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.imlet.2018.11.004_bib0045","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.it.2004.09.008","article-title":"Different checkpoints in human NK-cell activation","volume":"25","author":"Moretta","year":"2004","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2018.11.004_bib0050","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2249.2009.03983.x","article-title":"Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias","volume":"157","author":"Moretta","year":"2009","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2018.11.004_bib0055","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/1521-4141(200101)31:1<233::AID-IMMU233>3.0.CO;2-4","article-title":"Identification of NKp80, a novel triggering molecule expressed by human NK cells","volume":"31","author":"Vitale","year":"2001","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2018.11.004_bib0060","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/1521-4141(200003)30:3<787::AID-IMMU787>3.0.CO;2-I","article-title":"2B4 functions as a co-receptor in human NK cell activation","volume":"30","author":"Sivori","year":"2000","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2018.11.004_bib0065","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1084\/jem.194.3.235","article-title":"NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease","volume":"194","author":"Bottino","year":"2001","journal-title":"J. Exp. Med."},{"issue":"16","key":"10.1016\/j.imlet.2018.11.004_bib0070","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1182\/blood-2010-10-316125","article-title":"Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT","volume":"117","author":"Sivori","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.imlet.2018.11.004_bib0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells--a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2018.11.004_bib0080","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.imlet.2018.11.004_bib0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.smim.2014.01.006","article-title":"Development of human natural killer cells and other innate lymphoid cells","volume":"26","author":"Montaldo","year":"2014","journal-title":"Semin. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2018.11.004_bib0090","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.immuni.2017.03.008","article-title":"The ILC world revisited","volume":"46","author":"Diefenbach","year":"2017","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.imlet.2018.11.004_bib0095","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.immuni.2014.11.010","article-title":"Human RORgammat(+)CD34(+) cells are lineage-specified progenitors of group 3 RORgammat(+) innate lymphoid cells","volume":"41","author":"Montaldo","year":"2014","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.imlet.2018.11.004_bib0100","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1073\/pnas.1016257108","article-title":"CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells","volume":"108","author":"Vacca","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.imlet.2018.11.004_bib0105","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.it.2013.07.005","article-title":"Location and cellular stages of natural killer cell development","volume":"34","author":"Yu","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.imlet.2018.11.004_bib0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-065X.2006.00451.x","article-title":"Human natural killer cell development","volume":"214","author":"Freud","year":"2006","journal-title":"Immunol. Rev."},{"issue":"11","key":"10.1016\/j.imlet.2018.11.004_bib0115","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1002\/eji.201141760","article-title":"NK cells can generate from precursors in the adult human liver","volume":"41","author":"Moroso","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2018.11.004_bib0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1084\/jem.174.1.21","article-title":"In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors","volume":"174","author":"Mingari","year":"1991","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.imlet.2018.11.004_bib0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.immuni.2005.01.013","article-title":"A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells","volume":"22","author":"Freud","year":"2005","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.imlet.2018.11.004_bib0130","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1053\/j.gastro.2007.05.017","article-title":"Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells","volume":"133","author":"Chinen","year":"2007","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.imlet.2018.11.004_bib0135","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/mi.2014.63","article-title":"Identification of diverse innate lymphoid cells in human decidua","volume":"8","author":"Vacca","year":"2015","journal-title":"Mucosal Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2018.11.004_bib0140","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/eji.201546079","article-title":"The generation of human innate lymphoid cells is influenced by the source of hematopoietic stem cells and by the use of G-CSF","volume":"46","author":"Moretta","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/j.imlet.2018.11.004_bib0145","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1002\/eji.200425418","article-title":"The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and\/or dysfunction of triggering receptors involved in natural cytotoxicity","volume":"34","author":"Vitale","year":"2004","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2018.11.004_bib0150","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/intimm\/dxn014","article-title":"Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells","volume":"20","author":"Vitale","year":"2008","journal-title":"Int. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2018.11.004_bib0155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccell.2017.06.009","article-title":"Control of metastasis by NK cells","volume":"32","author":"Lopez-Soto","year":"2017","journal-title":"Cancer Cell"},{"issue":"9244","key":"10.1016\/j.imlet.2018.11.004_bib0160","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(00)03231-1","article-title":"Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population","volume":"356","author":"Imai","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.imlet.2018.11.004_bib0165","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jaci.2013.07.020","article-title":"Natural killer cell deficiency","volume":"132","author":"Orange","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2018.11.004_bib0170","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2017.04.014","article-title":"Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses","volume":"169","author":"Lavin","year":"2017","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.imlet.2018.11.004_bib0175","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/eji.201344272","article-title":"Effect of tumor cells and tumor microenvironment on NK-cell function","volume":"44","author":"Vitale","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/j.imlet.2018.11.004_bib0180","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41577-018-0061-z","article-title":"Natural killer cells and other innate lymphoid cells in cancer","volume":"18","author":"Chiossone","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.imlet.2018.11.004_bib0185","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2018.11.004_bib0190","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/hep.26328","article-title":"Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells","volume":"57","author":"Sprinzl","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.imlet.2018.11.004_bib0195","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"49","key":"10.1016\/j.imlet.2018.11.004_bib0200","doi-asserted-by":"crossref","first-page":"20847","DOI":"10.1073\/pnas.0906481106","article-title":"Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity","volume":"106","author":"Balsamo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.imlet.2018.11.004_bib0205","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/eji.201242783","article-title":"NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation","volume":"43","author":"Vacca","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2018.11.004_bib0210","doi-asserted-by":"crossref","first-page":"e1293210","DOI":"10.1080\/2162402X.2017.1293210","article-title":"IL15 induces a potent antitumor activity in NK cells isolated from malignant pleural effusions and overcomes the inhibitory effect of pleural fluid","volume":"6","author":"Croxatto","year":"2017","journal-title":"Oncoimmunology"},{"issue":"11","key":"10.1016\/j.imlet.2018.11.004_bib0215","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nrc3603","article-title":"The roles of TGFbeta in the tumour microenvironment","volume":"13","author":"Pickup","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"45","key":"10.1016\/j.imlet.2018.11.004_bib0220","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.imlet.2018.11.004_bib0225","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri1936","article-title":"Cancer despite immunosurveillance: immunoselection and immunosubversion","volume":"6","author":"Zitvogel","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.imlet.2018.11.004_bib0230","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1002\/eji.201343448","article-title":"Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC","volume":"43","author":"Balsamo","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2018.11.004_bib0235","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/eji.201142179","article-title":"Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor","volume":"42","author":"Balsamo","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2018.11.004_bib0240","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1038\/ncomms6639","article-title":"Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients","volume":"5","author":"Ali","year":"2014","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.imlet.2018.11.004_bib0245","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1158\/0008-5472.CAN-17-1891","article-title":"NK-cell editing mediates epithelial-to-Mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines","volume":"78","author":"Huergo-Zapico","year":"2018","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.imlet.2018.11.004_bib0250","doi-asserted-by":"crossref","first-page":"e1346766","DOI":"10.1080\/2162402X.2017.1346766","article-title":"Soluble NKG2D ligands limit the efficacy of immune checkpoint blockade","volume":"6","author":"Lopez-Soto","year":"2017","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.imlet.2018.11.004_bib0255","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1158\/1078-0432.CCR-13-1877","article-title":"Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer","volume":"20","author":"Webb","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.imlet.2018.11.004_bib0260","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","article-title":"Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death","volume":"11","author":"Ishida","year":"1992","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.imlet.2018.11.004_bib0265","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2016.04.025","article-title":"Identification of a subset of human natural killer cells expressing high levels of programmed death 1: a phenotypic and functional characterization","volume":"139","author":"Pesce","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"54","key":"10.1016\/j.imlet.2018.11.004_bib0270","doi-asserted-by":"crossref","first-page":"30465","DOI":"10.18632\/oncotarget.25770","article-title":"PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263","volume":"9","author":"Munari","year":"2018","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.imlet.2018.11.004_bib0275","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jtho.2018.04.017","article-title":"PD-L1 expression heterogeneity in non-small cell lung Cancer: defining criteria for harmonization between biopsy specimens and whole sections","volume":"13","author":"Munari","year":"2018","journal-title":"J. Thorac. Oncol."},{"issue":"13","key":"10.1016\/j.imlet.2018.11.004_bib0280","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1182\/blood-2008-06-164103","article-title":"Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity","volume":"113","author":"Pende","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.imlet.2018.11.004_bib0285","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1182\/blood-2004-09-3548","article-title":"Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)","volume":"105","author":"Pende","year":"2005","journal-title":"Blood"},{"issue":"5562","key":"10.1016\/j.imlet.2018.11.004_bib0290","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"issue":"1-2","key":"10.1016\/j.imlet.2018.11.004_bib0295","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.imlet.2013.09.022","article-title":"Understanding human NK cell differentiation: clues for improving the haploidentical hematopoietic stem cell transplantation","volume":"155","author":"Montaldo","year":"2013","journal-title":"Immunol. Lett."},{"issue":"5","key":"10.1016\/j.imlet.2018.11.004_bib0300","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2014-03-563817","article-title":"HLA-haploidentical stem cell transplantation after removal of alphabeta+ T and B cells in children with nonmalignant disorders","volume":"124","author":"Bertaina","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.imlet.2018.11.004_bib0305","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood-2017-04-779769","article-title":"Outcome of children with acute leukemia given HLA-haploidentical HSCT after alphabeta T-cell and B-cell depletion","volume":"130","author":"Locatelli","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2018.11.004_bib0310","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3389\/fimmu.2018.00984","article-title":"Human gammadelta T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias","volume":"9","author":"Pistoia","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2018.11.004_bib0315","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.it.2018.04.009","article-title":"NK cells mediate a crucial graft-versus-Leukemia effect in Haploidentical-HSCT to cure high-risk acute leukemia","volume":"39","author":"Locatelli","year":"2018","journal-title":"Trends Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2018.11.004_bib0320","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/eji.201445326","article-title":"IL-1beta inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors","volume":"45","author":"Ambrosini","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2018.11.004_bib0325","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.imlet.2016.06.003","article-title":"The Yin and Yang of innate lymphoid cells in cancer","volume":"179","author":"Carrega","year":"2016","journal-title":"Immunol. Lett."},{"issue":"9","key":"10.1016\/j.imlet.2018.11.004_bib0330","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ni.3800","article-title":"Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells","volume":"18","author":"Gao","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2018.11.004_bib0335","doi-asserted-by":"crossref","first-page":"8280","DOI":"10.1038\/ncomms9280","article-title":"NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures","volume":"6","author":"Carrega","year":"2015","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.imlet.2018.11.004_bib0340","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting Cancer immune control","volume":"172","author":"Bottcher","year":"2018","journal-title":"Cell"},{"issue":"26","key":"10.1016\/j.imlet.2018.11.004_bib0345","doi-asserted-by":"crossref","first-page":"11918","DOI":"10.1073\/pnas.1001749107","article-title":"Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression","volume":"107","author":"Vacca","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247818304577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247818304577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:34:31Z","timestamp":1759044871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247818304577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":69,"alternative-id":["S0165247818304577"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2018.11.004","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes?","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2018.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}]}}